Skip to main content

Table 1 Healthy normal and SLE patient characteristics

From: Increased expression of Mer tyrosine kinase in circulating dendritic cells and monocytes of lupus patients: correlations with plasma interferon activity and steroid therapy

 

Group 1

Group 2

Demographic

Lupus

Normal

Lupus

Normal

Age (years)

37.87 ± 10.23

38.41 ± 13.82

46.1 ± 14.0

40.5 ± 12.4

Sex F:M

21:1

5:9

26:3

8:7

Ethnicity

African-American

15

3

19

7

Hispanic

7

0

5

0

Caucasian

0

11

6

5

Asian

0

0

0

4

Parameter

    

Anti-dsDNA

10/22

 

18/29

 

Anti-Sm

8/22

 

16/29

 

Anti-Ro

6/22

 

12/29

 

Anti-La

2/22

 

1/29

 

Anti-cardiolipin

6/22

 

5/29

 

Lupus anticoagulant

2/22

 

5/29

 

Anti-B2 glycoprotein I

1/22

 

6/29

 

Anti–phospholipid

3/22

 

3/29

 

C3 low (<90)

6/22

 

7/29

 

C4 low (<16)

5/22

 

8/29

 

SLEDAI mean ± StDev

3.17 ± 3.13

 

5.6 ± 3.4